Happening Now
Shire (a Takeda company), is the manufacturer of VYVANSE and INTUNIV which unfortunately had experienced some interruption of the supply of both medications over the Christmas holiday period. ADHD Australia has been in contact with Shire, who manufactures INTUNIV 1mg and VYVANSE 70mg, and I am pleased to advise that both products have now returned…
Read More
Shire (a Takeda company), is the manufacturer of VYVANSE who have unfortunately experienced an interruption to their manufacturing for the VYVANSE 70mg. This has resulted in a shortage within Australia of this 70mg dosage strength only. They expect the supply of the VYVANSE 70mg will return to normal in February 2020. ADHD Australia has been…
Read More
ADHD Australia officially launched its new website on Thursday 5th December at a function hosted by the Westmead Hospital Foundation. At the event were representatives from each of the organisations involved in the collaborative approach made to the funder of the project, IMB Bank Community Foundation. IMB was represented by Ms Rachael Core who is…
Read More
The University of Sydney is undertaking research into the ‘Factors influencing medication-taking in people with ADHD.’ This USYD research project is looking to recruit 400 persons who have been diagnosed with, and taking prescribed medication for, ADHD to take part in this study. Study participant recruitment commences 1 October 2019. Study participant recruitment will cease…
Read More
The University of Surrey in the UK is undertaking an online research survey into the ‘disconnect between motor milestone achievement and motor development in ADHD with implications for intervention.’ This research project is totally online and each participant can participate in any or all of the sections of the study. It is totally up to…
Read More
The NSW Curriculum Review Interim Report is now available. It has been developed by the Review Lead, Professor Geoff Masters, as a basis for consultation on the broad directions for reform it identifies. It considers feedback from the 2018 consultation, alongside guidance from learning research, and reform initiatives from Australian and international jurisdictions. The Interim…
Read More
RMIT University and the School of Health and Biomedical Science, melbourne, in collaboration with Cricket Australia, seeks participation in their ADHD and physical activity studies. The RMIT research project is looking for children to participate in their research to examine if participating in the ‘Cricket Blast’ program benefits the children with ADHD and would like…
Read More
‘Shaping the future of disability policy for 2020 and beyond’ Submission by ADHD Australia in June 2019 The National Disability Policy Reform Team, from the Department of Social Services (DSS), invited the Australian community to take part in its national consultation process of reviewing disability policies. The current policy reform finishes next year so the…
Read More
Pharmaceutical Benefits Advisory Committee (PBAC) Submission by ADHD Australia in June 2019 ADHD Australia recently made an online submission to the next meeting of the Pharmaceutical Benefits Advisory Committee (PBAC) which is to be held in July. ADHD Australia undertook this advocacy step on behalf of all those living with ADHD in an effort to…
Read More
Productivity Commission into Mental Health contribution by ADHD Australia in April 2019 Scope of the Commission’s Review. ‘The Commission should consider the role of mental health in supporting economic participation, enhancing productivity and economic growth. It should make recommendations, as necessary, to improve population mental health, so as to realise economic and social participation and…
Read More